AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
Convention sessions, statement touch on environmental impact of veterinary medicine
Speakers at AVMA Convention 2023 will talk about the impacts of climate change and how environmental sustainability is an increasingly important topic…
JAVMA news
Externships provide students with a glimpse of international veterinary medicine
Two veterinary students took time out of their summer schedules for externships at the Office International des Epizooties in Paris
JAVMA news
FDA warns that compounding clenbuterol is illegal
In recent years, the availability of illegal clenbuterol formulations, produced as "compounded" drug product, has
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
JAVMA news
Topical gels: An option for panicky pill takers?
There are over 100 drugs advertised as products that can be administered topically to veterinary patients
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
JAVMA news
FDA to enhance pharmaceutical good manufacturing practices
The Food and Drug Administration announced an initiative to enhance the regulation of pharmaceutical manufacturing
AVMA news
Honeybee vaccine receives conditional license from USDA
The U.S. Department of Agriculture has granted a conditional license for a vaccine to protect honeybees against American foulbrood. The only…
JAVMA news
Nitrofuran ban in effect
The AVMA reminds veterinarians that the Food and Drug Administration has prohibited all uses of nitrofuran drugs
JAVMA news
Drug compounding position statement adopted
Compounding services have become more abundant as veterinary pharmacies multiply and enjoy financial success.
JAVMA news
Human drug shortages noted on new Web site
TAKE NOTICE Human drug shortages noted on new Web site When veterinarians find it hard to obtain an…
JAVMA news
Internet pharmacies and compounding are high-priority areas, FDA says
Posted on March 1, 2002 Â Since prior coverage on the issue of Internet pharmacies (see JAVMA, June 1, 2001, and Aug. 15, 2001), the AVMA continues…
JAVMA news
Final guidance on anthelmintics use available
The Food and Drug Administration has issued three final guidance documents regarding the use of anthelmintics
JAVMA news
AABP honors standouts
In Vancouver, the AABP recognized seven members deserving of the association's top honors.
AVMA news
Nominations open for 2024 AVMA Excellence awards
Summary: The nomination period is open for the 2024 AVMA Excellence Awards. The awards program recognizes contributions by veterinarians and…
JAVMA news
BSE: Could it happen here? Experts say probably not
As BSE continues its spread in Europe, US authorities are fine-tuning defensive actions to prevent the arrival and spread of the disease
AVMA news
Shortage of cancer drugs having devastating effects on patients, veterinarians
Chemotherapy drugs, including cisplatin and carboplatin, have been in short supply for months. The situation is affecting animal patients and…
JAVMA news
Buprenorphine rescheduled under stricter regulatory control
The Drug Enforcement Administration has rescheduled buprenorphine from a schedule V narcotic to a schedule III narcotic
JAVMA news
International animal health body addresses food safety, FMD, and animal welfare
More than 500 participants representing some 140 countries gathered in Paris this past May for the 70th annual General Session
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…